S&P 500   3,002.12 (+0.42%)
DOW   27,070.65 (+0.25%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
NFLX   294.23 (+2.78%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   3,002.12 (+0.42%)
DOW   27,070.65 (+0.25%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
NFLX   294.23 (+2.78%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Insys Therapeutics News Headlines (NASDAQ:INSY)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range
$0.23
MA: $23,687,640.18
$65,799,000.00
52-Week Range N/A
VolumeN/A
Average Volume9.52 million shs
Market Capitalization$21.71 million
P/E RatioN/A
Dividend YieldN/A
Beta3.21

Headlines

Insys Therapeutics (NASDAQ INSY) News Headlines

Source:
DateHeadline
Ex-Insys Chief Should Pay $350 Million Over Opioids, U.S. SaysEx-Insys Chief Should Pay $350 Million Over Opioids, U.S. Says
www.bloomberg.com - October 17 at 2:13 PM
Judge concerned about part of Insys executives convictionJudge concerned about part of Insys executives' conviction
www.reuters.com - October 16 at 10:19 PM
Opioid maker Insys says it aims to reach fully consensual Ch. 11 planOpioid maker Insys says it aims to reach 'fully consensual' Ch. 11 plan
www.reuters.com - October 8 at 10:34 PM
Insys Sells Subsys, Opioid at Center of Racketeering CaseInsys Sells Subsys, Opioid at Center of Racketeering Case
www.wsj.com - September 24 at 2:47 AM
Global Choroidal Neovascularization Drug Sales Market Industry Analysis, Product Capacity, Growth Demand and Future Forecast Period Till 2022Global Choroidal Neovascularization Drug Sales Market Industry Analysis, Product Capacity, Growth Demand and Future Forecast Period Till 2022
www.marketwatch.com - September 21 at 10:34 PM
Fentanyl Drug Finds New Home in First Opioid Crisis Bankruptcy DealFentanyl Drug Finds New Home in First Opioid Crisis Bankruptcy Deal
www.wsj.com - September 19 at 9:58 PM
Court Approves First Bankruptcy Sale of a Major Opioid DrugCourt Approves First Bankruptcy Sale of a Major Opioid Drug
finance.yahoo.com - September 19 at 9:58 PM
Insys Bankruptcy Plan Comes Up Short in Paying Justice DepartmentInsys Bankruptcy Plan Comes Up Short in Paying Justice Department
www.wsj.com - September 19 at 9:58 PM
Opioid maker Insys says payouts in liquidation to barely dent claimsOpioid maker Insys says payouts in liquidation to barely dent claims
www.reuters.com - September 17 at 9:25 PM
Maryland wants more time to review Insys deal for fentanyl sprayMaryland wants more time to review Insys' deal for fentanyl spray
www.reuters.com - September 10 at 3:56 PM
PG&E, Insys Bankruptcies Stumble in Bids for Bonuses, SeverancePG&E, Insys Bankruptcies Stumble in Bids for Bonuses, Severance
www.wsj.com - September 6 at 5:47 AM
Opioid makers bankruptcy results in Central Texas office swapOpioid maker's bankruptcy results in Central Texas office swap
www.bizjournals.com - August 26 at 3:28 PM
Insys still planning to auction off SubsysInsys still planning to auction off Subsys
seekingalpha.com - August 22 at 8:19 PM
Concerns about Insys employee wrongdoing justify new severance plan, says judgeConcerns about Insys employee wrongdoing justify new severance plan, says judge
www.reuters.com - August 22 at 8:19 PM
Insys creditors want assurance no severance goes to complicit employeesInsys creditors want assurance no severance goes to 'complicit' employees
www.reuters.com - August 21 at 8:36 PM
Choroidal Neovascularization Drug Market Analysis, Leading Players, Business Prospects Research Report Foresight To 2026Choroidal Neovascularization Drug Market Analysis, Leading Players, Business Prospects Research Report Foresight To 2026
www.marketwatch.com - August 12 at 10:37 PM
UPDATE: Hikma Buys Two Pipeline Products As Interim Profit JumpsUPDATE: Hikma Buys Two Pipeline Products As Interim Profit Jumps
www.morningstar.co.uk - August 9 at 11:53 AM
Former Insys exec to seek new trial citing Weil Gotshal conflictFormer Insys exec to seek new trial citing Weil Gotshal conflict
www.reuters.com - August 6 at 8:47 PM
Subsidiary of opioid maker Insys subsidiary sentenced over kickback schemeSubsidiary of opioid maker Insys subsidiary sentenced over kickback scheme
www.reuters.com - July 18 at 3:30 PM
Subsidiary of opioid maker Insys sentenced over kickback schemeSubsidiary of opioid maker Insys sentenced over kickback scheme
www.reuters.com - July 12 at 8:43 AM
States pause lawsuits against InsysStates pause lawsuits against Insys
seekingalpha.com - July 3 at 11:07 AM
Insys Pushes Opioid Claimants to Settle While Cash DwindlesInsys Pushes Opioid Claimants to Settle While Cash Dwindles
www.wsj.com - July 3 at 11:07 AM
FDA accepts Insys NDA for naloxone nasal spray for opioid overdoseFDA accepts Insys' NDA for naloxone nasal spray for opioid overdose
seekingalpha.com - July 3 at 11:07 AM
FDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid OverdoseFDA Accepts New Drug Application for INSYS Therapeutics’ Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose
finance.yahoo.com - July 3 at 11:07 AM
States agree to pause lawsuits against bankrupt opioid maker InsysStates agree to pause lawsuits against bankrupt opioid maker Insys
www.reuters.com - July 2 at 3:31 PM
Firm Retention Summary: Insys Therapeutics Inc.Firm Retention Summary: Insys Therapeutics Inc.
www.wsj.com - June 26 at 3:19 PM
Update On Avenue Therapeutics: Phase 3 Reduces Risk, Shares Are A BargainUpdate On Avenue Therapeutics: Phase 3 Reduces Risk, Shares Are A Bargain
seekingalpha.com - June 14 at 8:12 AM
Insys Therapeutics stock jumps after bankruptcy court approves First Day motionsInsys Therapeutics' stock jumps after bankruptcy court approves 'First Day' motions
www.marketwatch.com - June 12 at 7:36 AM
INSYS Therapeutics, Inc. Receives Court Approval of "First Day" MotionsINSYS Therapeutics, Inc. Receives Court Approval of "First Day" Motions
www.marketwatch.com - June 12 at 7:36 AM
INSYS Therapeutics, Inc. Receives Court Approval of “First Day” MotionsINSYS Therapeutics, Inc. Receives Court Approval of “First Day” Motions
finance.yahoo.com - June 12 at 7:36 AM
Insys Therapeutics' stock jumps after bankruptcy court approves 'First Day' motionsInsys Therapeutics' stock jumps after bankruptcy court approves 'First Day' motions
finance.yahoo.com - June 12 at 7:36 AM
U.S. STOCKS ON THE MOVE-Beyond Meat, Legacy Reserves, CymaBay Therapeutics, Insys TherapeuticsU.S. STOCKS ON THE MOVE-Beyond Meat, Legacy Reserves, CymaBay Therapeutics, Insys Therapeutics
www.nasdaq.com - June 11 at 3:21 PM
Arizona-based Insys Therapeutics files for bankruptcy protection June 10Arizona-based Insys Therapeutics files for bankruptcy protection June 10
www.msn.com - June 11 at 6:16 AM
Chandler opioid maker files for bankruptcy protectionChandler opioid maker files for bankruptcy protection
finance.yahoo.com - June 11 at 6:16 AM
Opioid maker Insys Therapeutics files Chapter 11 bankruptcy after corruption chargesOpioid maker Insys Therapeutics files Chapter 11 bankruptcy after corruption charges
www.usatoday.com - June 10 at 3:17 PM
Insys, the Opioid Drug Maker, Files for BankruptcyInsys, the Opioid Drug Maker, Files for Bankruptcy
www.nytimes.com - June 10 at 3:17 PM
Insys Therapeutics Sinks After Filing for BankruptcyInsys Therapeutics Sinks After Filing for Bankruptcy
www.thestreet.com - June 10 at 3:17 PM
Its over. Insys to sell assets under bankruptcy filing; shares off 58% premarketIt's over. Insys to sell assets under bankruptcy filing; shares off 58% premarket
seekingalpha.com - June 10 at 7:24 AM
INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy LiabilitiesINSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities
www.marketwatch.com - June 10 at 7:24 AM
Opioid Drugmaker Insys Therapeutics Files for BankruptcyOpioid Drugmaker Insys Therapeutics Files for Bankruptcy
www.nytimes.com - June 10 at 7:24 AM
3 Marijuana Stocks I Wouldn't Touch With a 10-Foot Pole Right Now3 Marijuana Stocks I Wouldn't Touch With a 10-Foot Pole Right Now
finance.yahoo.com - June 9 at 3:19 PM
Insys to Pay $225 Million to Settle Opioid-Sales ProbeInsys to Pay $225 Million to Settle Opioid-Sales Probe
www.msn.com - June 7 at 4:20 PM
Unit of drugmaker Insys to plead guilty to U.S. opioid bribe schemeUnit of drugmaker Insys to plead guilty to U.S. opioid bribe scheme
finance.yahoo.com - June 7 at 6:35 AM
Insys Therapeutics Board Members Resign After $225M DOJ SettlementInsys Therapeutics Board Members Resign After $225M DOJ Settlement
www.benzinga.com - June 7 at 6:35 AM
Call Options Opened After Insys Therapeutics Stock HaltCall Options Opened After Insys Therapeutics Stock Halt
finance.yahoo.com - June 7 at 6:35 AM
Insys triggers second volatility halt, up 45%Insys triggers second volatility halt, up 45%
seekingalpha.com - June 6 at 3:22 PM
Opioid manufacturer Insys Therapuetics agrees to pay $225 million to settle criminal and civil investigationsOpioid manufacturer Insys Therapuetics agrees to pay $225 million to settle criminal and civil investigations
abcnews.go.com - June 6 at 3:22 PM
Chandler opioid maker agrees to $225M settlement, admits to bribing docsChandler opioid maker agrees to $225M settlement, admits to bribing docs
finance.yahoo.com - June 6 at 3:22 PM
Opioid manufacturer agrees to pay $225 million to settle corruption caseOpioid manufacturer agrees to pay $225 million to settle corruption case
finance.yahoo.com - June 6 at 3:22 PM
Insys to Pay $225 Million to Settle U.S. Opioid-Sales ProbesInsys to Pay $225 Million to Settle U.S. Opioid-Sales Probes
www.msn.com - June 6 at 7:32 AM
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel